Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Remarks:
Human patch test
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Peer reviewed research.
The research was performed after reported sensitisation by those in contact with genipin

Data source

Reference
Reference Type:
publication
Title:
Genipin in Temporary Jagua Tattoos – Black Dye Causing Severe Allergic Dermatitis
Author:
Bircher, Andreas J. MD
Year:
2019
Bibliographic source:
Dermatitis: 11/12 2019 - Volume 30 - Issue 6

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Human patch test performed following reported allergic reactions among those in contact with genipin based products to confirm the components causing allergic reactions
Genipin was demonstrated to be a skin sensitiser to humans.
GLP compliance:
not specified
Type of study:
patch test
Justification for non-LLNA method:
Human study

Test material

Constituent 1
Chemical structure
Reference substance name:
Genipin
EC Number:
636-196-5
Cas Number:
6902-77-8
Molecular formula:
C11H14O5
IUPAC Name:
Genipin
Test material form:
solid: particulate/powder

In vivo test system

Test animals

Species:
other: Human
Sex:
not specified

Study design: in vivo (non-LLNA)

Induction
Route:
epicutaneous, semiocclusive
Vehicle:
DMSO
Concentration / amount:
1%
Day(s)/duration:
2 days application
Adequacy of induction:
other: Typical concentration used in cosmetic products
Challenge
No.:
#1
Route:
epicutaneous, semiocclusive
Vehicle:
DMSO
Concentration / amount:
1%
Day(s)/duration:
2
Adequacy of challenge:
other: Concentration used in cosmetic products
No. of animals per dose:
Not specified
Details on study design:
Methods described as 'standard European methods for human patch testing'
Challenge controls:
The study was performed using other ingredients present in the cosmetic leading to an allergic reaction, including citric acid and potassium sorbate - these proved negative and therefore acting as controls
Positive control substance(s):
no

Results and discussion

Positive control results:
Not tests

In vivo (non-LLNA)

Results
Reading:
other: Observations over several days from repeated application
Hours after challenge:
72
Group:
test chemical
Dose level:
1% in DMSO
Clinical observations:
No other adverse effect recorded
Remarks on result:
positive indication of skin sensitisation
Remarks:
Number of volunteers and number with reactions are not reported.

Applicant's summary and conclusion

Interpretation of results:
Category 1 (skin sensitising) based on GHS criteria
Remarks:
Reported as clear positive effects
Conclusions:
In view of the human exposure assessment and patch test, no further testing is considered to be necessary. The substance is classified as Skin Sens 1